We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Discovery May Help Doctors Treat Infertility

By Biotechdaily staff writers
Posted on 29 Aug 2005
A new study shows that fertility drugs may be ineffective for women who lack a gene called the estrogen receptor beta, suggesting that women who lack this receptor may need alternative infertility treatments. This discovery was reported in the August 2005 issue of Endocrinology.

The estrogen receptor beta is one of two estrogen proteins that mediate the effects of estrogen hormones and are present throughout female reproductive tissue. In mice that were genetically engineered to lack the estrogen receptor beta, fertility drugs did not improve ovulation rates, indicating that this receptor plays a critical role in ovulation.

"What we found is that the beta estrogen receptor plays a role in moving the egg outside the ovary so it can be fertilized,” said Kenneth Korach, Ph.D., laboratory chief at the U.S. National Institute of Environmental Health Sciences (NIEHS, Bethesda, MD, USA), where the research took place. "We never knew before what function this receptor played in reproduction.”

If the results from this animal study are found to be applicable to humans, a simple blood test will be able to provide enough information to determine if a genetic mutation may be altering the function of the estrogen receptor beta. Coupled with other information from medical tests, this test will also help diagnose infertility and help determine treatment options.

It was generally thought that there was only one receptor, the alpha receptor, that responded to estrogen. It was not until 1996 that the estrogen receptor beta was discovered. According to the current study, the beta receptor plays a more significant role in ovarian function than the alpha receptor.

The beta receptor is also known to respond to environmental and dietary chemicals that can mimic the effects of estrogen and stimulate the body's natural hormones. One example of this is genistein, a component of soy products. The new findings suggest that such environmental exposures could interact with estrogen receptor beta and possibly alter ovarian function. An earlier NIEHS study used an in vitro approach to reveal the role that estrogen receptors play in ovulation.

"The tools and animal models necessary to do these types of studies have only recently become available, but are already helping us to better understand the role of estrogen in the ovary,” stated lead author John Couse, Ph.D.




Related Links:
National Institute of Environmental Health Sciences

New
Gold Member
Automatic Hematology Analyzer
CF9600
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
New
Automated Urinalysis Solution
UN-9000
New
Multi-Chamber Washer-Disinfector
WD 390

Latest BioResearch News

Study Identifies Protein Changes Driving Immunotherapy Resistance in Multiple Myeloma
29 Aug 2005  |   BioResearch

Genetic Analysis Identifies BRCA-Linked Risks Across Multiple Cancers
29 Aug 2005  |   BioResearch

Study Identifies Hidden B-Cell Mutations in Autoimmune Disease
29 Aug 2005  |   BioResearch